A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max response rates have not yet been observed; strict continuation criteria at three months in this ...

AnaptysBio announces positive results from phase 2b trial of rosnilimab to treat rheumatoid arthritis: San Diego Thursday, June 5, 2025, 18:00 Hrs [IST] AnaptysBio, Inc., a clinic ...

Individuals with IBD, especially CD, have an increased risk for myocardial infarction, ischemic heart disease, cerebrovascular accident, and major adverse cardiovascular events.

Lung-related conditions and symptoms associated with rheumatoid arthritis (RA) include interstitial lung disease, lung nodules, and small airway obstruction. Rheumatoid arthritis (RA) is an ...

BALTIMORE, May 08, 2025--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...

Individuals with RA may be at an increased risk of heart disease, which is a risk factor for heart failure. This risk can be mitigated through managing RA and other lifestyle changes. Inflammation ...

The Food and Drug Administration has designated Hadlima (adalimumab-bwwd) an interchangeable biosimilar to Humira (adalimumab).

Tottenham fired manager Ange Postecoglou on Friday, two weeks after the Australian led the club to the Europa League title to end its 17-year wait for a trophy. Tottenham beat ...

And remember to listen to your body and not overdo it, especially during an RA flare. Family and friends are often your first line of support, but online and in-person groups offer interaction ...

The FDA has expanded the interchangeable designation for Yuflyma (adalimumab-aaty), a biosimilar to Humira, to include all presentations.